Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics

Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy, Molecular Cancer

CAR-T cell therapy: current limitations and potential strategies

Cellular Therapy in NSCLC: Between Myth and Reality

CAR-T Cells Targeting Immune Checkpoint Pathway Players

Frontiers CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer

CRISPR in cancer biology and therapy

Current advances of CRISPR-Cas technology in cell therapy - ScienceDirect

Promises and challenges of adoptive T-cell therapies for solid tumours

Frontiers Emerging Strategies in TCR-Engineered T Cells

Cancers, Free Full-Text

Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma